Current incidence and residual risk of hepatitis B infection among blood donors in the United States

Transfusion

Volumn 49, Issue 8, 2009, Pages 1609-1620

  Zou, Shimian ^a   Stramer, Susan L ^b   Notari, Edward P ^b   Kuhns, Mary C ^b   Krysztof, David ^b   Musavi, Fatemeh ^b   Fang, Chyang T ^b   Dodd, Roger Y ^b  

^a AMERICAN RED CROSS BLOOD SERVICES   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN;

ARTICLE; BLOOD DONOR; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INCIDENCE; INFECTION RISK; NONHUMAN; RESIDUAL INFECTION RISK; RISK ASSESSMENT; SEROCONVERSION; SERODIAGNOSIS; UNITED STATES;

BLOOD DONORS; FEMALE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HUMANS; INCIDENCE; MALE; MODELS, BIOLOGICAL; RISK FACTORS; TIME FACTORS; UNITED STATES; VACCINATION;

EID: 68149096675     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2009.02195.x     Document Type: Article

References (27)

1. Dodd RY, Notari EP 4th., Stramer SL. Current prevalence and incidence of infectious disease markers and estimated window period risk in the American Red Cross blood donor population. Transfusion 2002 42 : 975 9.
2. Kleinman SH, Strong DM, Tegtmeier GG, Holland PV, Gorlin JB, Cousins C, Chiacchierini RP, Pietrelli LA Hepatitis B virus (HBV) DNA screening of blood donations in minipools with the COBAS AmpliScreen HBV test. Transfusion 2005 45 : 1247 57.
3. Koppelman MH, Sjerps MC, Reesink HW, Cuypers HT. Evaluation of COBAS Ampli Prep nucleic acid extraction in conjunction with COBAS AmpliScreen HBV DNA, HCV RNA and HIV-1 RNA amplification and detection. Vox Sang 2005 89 : 193 200.
4. Margaritis AR, Brown SM, Seed CR, Kiely P, D'Agostino B, Keller AJ. Comparison of two automated nucleic acid testing systems for simultaneous detection of human immunodeficiency virus and hepatitis C virus RNA and hepatitis B virus DNA. Transfusion 2007 47 : 1783 93.
5. Jarvis L, Becker J, Tender A, Cleland A, Queiros L, Aquiar A, Azevedo J, Aprili G, Bressan F, Torres P, Nieto S, Ursitti A, Montoro J, Vila E, Ramada C, Saldanha J. Evaluation of the Roche cobas s 201 system and cobas TaqScreen multiplex test for blood screening: a European multicenter study. Transfusion 2008 48 : 1853 61.
6. Biswas R, Tabor E, Hsia CC, Wright DJ, Laycock ME, Fiebig EW, Peddada L, Smith R, Schreiber GB, Epstein JS, Nemo GJ, Busch MP. Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection. Transfusion 2003 43 : 788 98.
7. Yoshikawa A, Gotanda Y, Itabashi M, Minegishi K, Kanemitsu K, Nishioka K, the Japanese Red Cross NAT Screening Research Group. Hepatitis B NAT virus-positive blood donors in the early and late stages of HBV infection: analyses of the window period and kinetics of HBV DNA. Vox Sang 2005 88 : 77 86.
8. Stramer SL. Pooled hepatitis B virus DNA testing by nucleic acid amplification: implementation or not. Transfusion 2005 45 : 1242 6.
9. Fang CT. Blood screening for HBV DNA. J Clin Virol 2006 36 Suppl 1 : S30 S32.
10. Kleinman SH, Busch MP. Assessing the impact of HBV NAT on window period reduction and residual risk. J Clin Virol 2006 35 Suppl 1 : S34 40.
11. Comanor L, Holland P. Hepatitis B virus blood screening: unfinished agendas. Vox Sang 2006 91 : 1 12.
12. Kuhns MC, Busch MP. New strategies for blood donor screening for hepatitis B virus. Mol Diag Ther 2006 10 : 77 91.
13. Zou S, Stramer SL, Notari EP, Musavi F, Fang CT, Dodd RY. Estimating current incidence and residual risk of hepatitis B viral infection among blood donors in the United States through a novel approach. Vox Sang 2008 95 Suppl 1 : 22 3 (abstract).
14. Zou S, Musavi F, Notari EP IV., Fujii K, Dodd RY, for the ARCNET Study Group. Prevalence of selected viral infections among temporarily deferred donors who returned to donate blood - American Red Cross blood donor study. Transfusion 2005 45 : 1593 600.
15. Stramer SL, Foster GA, Notari EP IV. HBV DNA PCR positive rates of antibody to hepatitis B core (anti-HBc) repeat reactive (RR) donors; implications for reentry protocols. Transfusion 2006 46 Suppl 9S : 21A (abstract).
16. Kleinman S, Busch M, Rawal B, Glynn S, for the Retrovirus Epidemiology Donor Study. Evaluation of HBsAg neutralization test positive (Neut Pos) donors with negative (Neg) anti-HBc. Transfusion 1998 38 Suppl 10S : 92S.
17. Zou S, Notari EP IV., Musavi F, Dodd RY, for the ARCNET Study Group. Current impact of the confidential unit exclusion option. Transfusion 2004 44 : 651 7.
18. Korelitz JJ, Busch MP, Kleinman SH, Williams AE, Gilcher RO, Ownby HE, Schreiber GB, for the National Heart, Lung, and Blood Institute Retrovirus Epidemiology Donor Study. A method for estimating hepatitis B virus incidence rates in volunteer blood donors. Transfusion 1997 37 : 634 40.
19. Busch MP, Glynn SA, Stramer SL, Strong DM, Caglioti S, Wright DJ, Pappalardo B, Kleinman SH, for the NHLBI-REDS NAT Study Group. A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors. Transfusion 2005 45 : 254 64.
20. Brookmeyer R, Quinn TC. Estimation of current human immunodeficiency virus incidence rates from a cross-sectional survey using early diagnostic tests. Am J Epidemiol 1995 141 : 166 72.
21. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med 1996 334 : 1685 90.
22. SAS/STAT user's guide, version 6. 4th ed. Cary (NC) : SAS Institute 1989.
23. Crystal ball software 2000.2 user manual. Denver (CO) : Decisioneering, Inc 2000.
24. Wright DJ, Glynn S, Busch M, Kleinman S, Watanabe K, Schreiber G, for the NHLBI Retrovirus Epidemiology Donor Study. Estimation of hepatitis B incidence rates based on HBsAg marker. Transfusion 1999 39 Suppl : 106S 107S (Abstract).
25. Hollinger FB. Hepatitis B virus infection and transfusion medicine: science and the occult. Transfusion 2008 48 : 1001 26.
26. Brookmeyer R, Quinn T, Shepherd M, Mehendale S, Rodrigues J, Bollinger R. The AIDS epidemic in India: a new method for estimating current human immunodeficiency virus (HIV) incidence rates. Am J Epidemiol 1995 142 : 709 13.
27. Laperche S, Maniez M, Barlet V, El Ghouzzi MH, Le Vacon F, Levayer T, Lunel F, Morel P, Mouillot L, Piquet Y, Pillonel J. A revised method for estimating hepatitis B virus transfusion residual risk based on antibody to hepatitis B core antigen incident cases. Transfusion 2008 48 : 2308 14.